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The recent introduction (I) and subscqucnt clinical applica- 
tions (2) of percutaneous aortic valvuloplasty follows a 
familiar pattern regarding new therapeutic agents or meth- 
od<. Early wthusiastic support is often followed by reas- 
sessment and disillusionment. In the modern era of mass 
commun!~ation, this process seems to have become con- 
densed and accelerated, with widespread acceptance and 
public awareness of new drugs and technologies occurring 
more mpidly and often prema!orclj 
The grrsent study. The re,m” of Bernard et al. (3) 
evaluating their experience with percutaneous aortic valvu- 
lo&ty in the elderly, reported in this issue of the Journal, 
highilshts a case in point. Their results with p:reotaneous 
aortic valvuloplasty proved to be far inferior to those ob- 
tained with standard open aortic valve replacement, yet the 
percutaneous approach has in some zense already been 
introduced as accepted clinical practice. tadfed, rhe group 
(4) responsible fc: pioneering the Introduction of percutane- 
ous aortic valvuloplasty provided follow-up hemodynamic 
data on only 25% of their initial series of 218 patients. 
In this month’s report, Bernard et al. (3) note that only 
6.5% of patients who underwent valvuloplasty were alive 
without reopcration at a mean follow-up period of <2 years. 
Thirty-five percent of patients treated with valvuloplasty 
required subsequent aortic valve replacement at an average 
period of <I6 months after the initial percutaneous proce- 
dure. An additional 35% of patients died of heart failure, 
presumably due to residual or recurrent aortic stenosis. In 
this series, the 36% decrease in Doppkrdetemtined mean 
grrdiwt obtained with valvulnplasty, yielding a 41. I-mm Hg 
residual mean gradient, compares unfavorably with an 82% 
reduction in mean gradient and a 12.mm Kg residual gradient 
obtained with aortic valve replacement. These results for 
both valvuloplasty and aortic valve replacement are similar 
to those of most other inver!igators. 
Previous studies. Letac et al. (4). responsible for popu- 
larizing the valvuloplasty procedure, claim that “balloon 
aortic valvuloplasty is the procedure of choice in patients 
greater than 75 to 80 years old.” However, in their series. in 
68% of patients undergoing valvuloplasty. aortic valve area 
remained <I cm2, which is w~nlly considered to represent 
moderately severe aortic stenosis. Critical aortis stenosis 
(valve awe <0.7 cm’) remained in 26% of patients. These 
results were obtained at the Cost of a 4.6% in-hospital 
mortality rate and a 17% mortaliry rate at a mean follow-up 
period of 8 met&. 
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rate of stroke and a 13% rate of ~vascu;ar complications. In 
contrast, aortic valve replacement can be petformed with a 
mortality rate of ~5% and an 8096 to 90% survival rate at 5 
years (3). The long-temt survival rate after aortic valve 
replacement in thr series of patients >80 years of age 
reported by Culliford et al. (6) duplicates that of t!x gccnerai 
population ut this age grottp, with no late cardiac deaths at 3 
years. 
Bernard et al. (3) arc to be congratulated for objectively 
reporting their negative results with the percutaneow ap 
preach. Nevertt:eless, it is somewhat alarming that these 
ii: :a are obtained by way of a nonrandomized, retrospective 
trial. In retrospect, the patients were inadequately informed 
of the risks and benefits of the percutaneous approach. and 
most, Iherefore. chose the sect&gly more con&dive, but 
u!timately iess beneficial, treatment. 
Clinical implications. Unfortunately, the results obtained 
with percutaneous aortic valvuloplasty are not entirely un- 
expected. The cardiac surgeon aid the pathologist alike are 
orovided with an excellent insieht into the shortcomines of 
ihia technique. The “rock.h&” calcium-laden val& of 
senile calcific stenosis is an unyielding, fused mass of 
calcium and fibrosis. The commissuref are all but undistin- 
guishable. Effective pneumatic dilation of such a severely 
diseased valve is highly unlikely. as has been noted in tat 
least one necmpsy series (7). Elderly patients. perhaps most 
likely to benefit from a percutaneous rather than an open 
technique. characteristically have the most severe valve 
defortttities that are least suitable for balloon dilation. Better 
results might be obtainable in younger patienrs with less 
disease, hut these patients would most likely be subjected to 
multiple procedures over the years with aggregative morbid- 
ity and mortality. 
Conclusions. Bernard et al. (3) provide important clinical 
data regarding percutaneous aortic valvuloplasty in the 
elderly. Their report clearly highlights the drawhncks of the 
percutaneous approach. Their inabiiity to find any subgroup 
of patients who are at partieulw risk for failure of percuta- 
neou~ valvuloplasty, or conversely, are most likely to ben- 
efit, suggests that future clinical applications of this ap 
proach should be abandoned, except in the most unusual of 
circumstances. Open aortic valve replacement should re- 

